Virtual Chip-Seq: Predicting Transcription Factor Binding

Total Page:16

File Type:pdf, Size:1020Kb

Virtual Chip-Seq: Predicting Transcription Factor Binding bioRxiv preprint doi: https://doi.org/10.1101/168419; this version posted February 28, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Virtual ChIP-seq: predicting transcription factor binding 2 by learning from the transcriptome 1,2,3 1,2,4,5 3 Mehran Karimzadeh and Michael M. Hoffman 1 4 Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada 2 5 Princess Margaret Cancer Centre, Toronto, ON, Canada 3 6 Vector Institute, Toronto, ON, Canada 4 7 Department of Computer Science, University of Toronto, Toronto, ON, Canada 5 8 Lead contact: michael.hoff[email protected] 9 February 28, 2018 10 Abstract 11 Motivation: 12 Identifying transcription factor binding sites is the first step in pinpointing non-coding mutations 13 that disrupt the regulatory function of transcription factors and promote disease. ChIP-seq is 14 the most common method for identifying binding sites, but performing it on patient samples is 15 hampered by the amount of available biological material and the cost of the experiment. Existing 16 methods for computational prediction of regulatory elements primarily predict binding in genomic 17 regions with sequence similarity to known transcription factor sequence preferences. This has limited 18 efficacy since most binding sites do not resemble known transcription factor sequence motifs, and 19 many transcription factors are not even sequence-specific. 20 Results: 21 We developed Virtual ChIP-seq, which predicts binding of individual transcription factors in new 22 cell types using an artificial neural network that integrates ChIP-seq results from other cell types 23 and chromatin accessibility data in the new cell type. Virtual ChIP-seq also uses learned asso- 24 ciations between gene expression and transcription factor binding at specific genomic regions. 25 This approach outperforms methods that use transcription factor sequence preferences in the 26 form of position weight matrices, predicting binding for 34 transcription factors (accuracy > 0:99; 27 Matthews correlation coefficient > 0:3). In at least one validation cell type, performance of Virtual 28 ChIP-seq is higher than all participants of the DREAM Challenge for in vivo transcription factor 29 binding site prediction in 4 of 9 transcription factors that we could compare to. 30 Availability: 31 The datasets we used for training and validation are available at https://virchip.hoffmanlab.org. 32 We have deposited in Zenodo the current version of our software (http://doi.org/10.5281/ 33 zenodo.1066928), datasets (http://doi.org/10.5281/zenodo.823297), and the predictions for 34 34 transcription factors on Roadmap cell types (http://doi.org/10.5281/zenodo.1066932). 1 bioRxiv preprint doi: https://doi.org/10.1101/168419; this version posted February 28, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 35 1 Introduction 36 Transcription factor (TF) binding regulates gene expression. Each TF can harmonize expression of 37 many genes by binding to genomic regions that regulate transcription. Cellular machinery utilizes 38 these master regulators to regulate key cellular processes and adapt to environmental stimuli. 39 Alteration in sequence or quantity of a given TF can impact expression of many genes. In fact, 40 these alterations can be the primary cause of hereditary disorders, complex disease, autoimmune 1 41 defects, and cancer . 42 TFs bind to accessible chromatin based on weak non-covalent interactions between amino acid 2 3 43 residues and nucleic acids. DNA's primary structure (sequence) , secondary structure (shape) , and 4 44 tertiary structure (conformation) all play roles in TF binding. Many TFs form a complex with 45 others as well as chromatin-binding proteins and therefore bind to DNA indirectly. Some TFs also 46 have different isoforms and undergo various post-translational modifications. In vitro assays, such 5 47 as high throughput systematic evolution of ligands by exponential enrichment (HT-SELEX) and 6 48 protein binding microarrays , have provided a compelling understanding of context-independent 7 49 TF sequence and shape preference . Yet, for the aforementioned reasons, performance of models 8,9 50 trained on these in vitro data are poor when applied on in vivo experiments . To address this 51 challenge, we must explore how to better model DNA shape, TF-TF interactions, and context- 52 dependent TF binding. 10 53 Chromatin immunoprecipitation and sequencing (ChIP-seq) and similar methods, such as 11 12 54 ChIP-exo and ChIP-nexus , can map the presence of a given TF in the genome of a biological 55 sample. To map TFs, these assays require a minimum of 1,000,000 to 100,000,000 cells, depending 56 on properties of the TF itself and available antibodies. Such large numbers of cells are not often 57 available from clinical samples. Therefore, it is impossible to systematically assess TF binding in 58 most disease systems. Assessing chromatin accessibility through transposase-accessible chromatin 13 59 using sequencing (ATAC-seq) , however, requires only hundreds or thousands of cells. One can 60 obtain this many cells from many more clinical samples. While chromatin accessibility does not de- 61 termine TF binding, several methods use this information together with knowledge of TF sequence 14,15,16 62 preference, genomic conservation, and other genomic features to predict TF binding . 63 Predicting TF binding with motif discovery tools within chromatin accessible regions has helped 17 64 us understand the role of several TFs in various disease. For example, He et al. used motif 65 discovery tools to identify role of OCT1 and NKX3-1 after prolonged androgen stimulation in 18 66 prostate cancer. Similarly, Bailey et al. discovered that a known breast cancer risk polymorphism 67 is an ESR1 binding site in its wild-type context. This ESR1 binding site is also a hotspot of 68 somatic non-coding mutations in its vicinity. We propose that using more accurate tools to predict 69 TF binding will allow understanding the role of TF binding in more contexts. 70 Previous studies have used various approaches to predict TF binding. Several methods use unsu- 14 15 71 pervised approaches such as hierarchical mixture models or hidden Markov models to identify 72 transcription factor footprint using chromatin accessibility data. These approaches use sequence 73 motif scores to attribute footprints to different transcription factors. Convolutional neural network 74 models can boost precision by learning sequence preferences from in vivo, rather than in vitro 20,21 75 data . Variation in sequence specificity and cooperative binding of some transcription factors 76 prevents these methods from accurately predicting binding of all transcription factors. A more re- 77 cent approach uses matrix completion to impute TF binding using a 3-mode tensor representing 22 78 genomic positions, cell types, and TF binding . This method doesn't rely on sequence specificity, 79 but can only predict TF binding in well-studied cell types with many ChIP-seq datasets. This 80 means one cannot use it to predict binding in a cell type where ChIP-seq is not possible, such as 81 limited clinical samples. 82 Identifying the best approach for predicting TF binding remains a challenge, because most 2 a100 75 50 ● 25 0 RB1 TBP PML MAZ SIX5 TAF1 ATF1 TAF7 ATF7 BMI1 MXI1 ZZZ3 E2F1 MTA3 MTA1 EZH2 ZHX1 PHF8 HSF1 ZHX2 BRF1 BRF2 RFX5 PBX3 UBTF RNF2 CBX2 CBX3 CBX8 CBX5 BDP1 CHD1 CHD7 CHD4 CHD2 IKZF1 SMC3 MBD4 SIRT6 ZMIZ1 SIN3B SIN3A CREM − NONO ZFP36 EP300 KAT2B KAT2A SUZ12 H3F3A SAP30 TFDP1 FOXP2 NELFE ZBED1 CTBP2 GTF2B RAD21 NR3C1 NR1H2 RBBP5 MYBL2 HDAC2 HDAC6 HDAC1 HCFC1 CCNT2 BRCA1 CREB1 CEBPZ KDM4A KDM5A KDM5B CEBPD KDM1A SMAD2 RCOR1 NCOR1 TRIM22 TRIM28 HMGN3 WHSC1 ZNF143 ARID3A NANOG NFATC1 GTF2F1 GTF3C2 WRNIP1 SREBF2 SETDB1 TARDBP POLR3A POLR2A POLR3G CREBBP TBL1XR1 HA ZC3H11A CREB3L1 SUPT20H ZKSCAN1 NEUROD1 100 ● 75 ● ● ● ● ● Peaks with sequence motif (%) Peaks ● 50 ● ● bioRxiv preprint ● 25 ● ● ● ● contrast, most MAFK peaksing both sequence contain motif its of sequenceto motif the TFs and same with show TF, motif centralenrichment such occupancy enrichment. as of ATF3, 50% centralwhere or enrichment more. of 50% the or motifTFs more is where of also less peaks low. thanIndividual have In 50% of the points: peaks sequence outliers have motifdian. beyond the Box (high sequence a range: motif motif interquartile whisker. (low range occupancy,distribution motif (IQR). among blue). Whisker: occupancy, datasets most green), from extreme and different valueChIP-seq TFs cell within peaks types quartile for and a TF replicates.Figure with Horizontal any line 1: JASPAR of sequence boxplot: motif from me- the TF's family. Boxplots show the 0 SP2 SP1 SP4 YY1 JUN SRF FOS MNT IRF4 IRF3 MYB MAX IRF2 SPI1 MYC TAL1 ATF2 ATF3 NFIC E2F4 ELF1 E2F6 KLF5 BATF PAX5 PAX8 ELK1 ELK4 TCF3 TCF7 EBF1 ZEB1 ETV6 ETS1 BCL3 USF1 NFE2 USF2 RFX1 NFYA PBX2 SOX6 NRF1 RELA JUND CTCF NFYB REST CUX1 MAFF EGR1 RXRA MAFK STAT1 STAT3 GFI1B MEIS2 GATA2 GATA3 GATA1 TCF12 NR2F2 FOSL2 FOSL1 FOXA1 FOXA2 CTCFL TEAD4 THAP1 HNF4A NR2C2 BACH1 GABPA MEF2A RUNX3 RUNX1 FOXM1 HNF4G MEF2C CEBPB ESRRA SMAD1 STAT5A ZNF384 ZNF217 ZNF274 ZNF263 TCF7L2 ZNF207 NFE2L2 ZBTB33 BCL11A ZBTB7A BCLAF1 POU5F1 SREBF1 POU2F2 BHLHE40 SMARCA4 SMARCB1 SMARCC1 doi: not certifiedbypeerreview)istheauthor/funder.Allrightsreserved.Noreuseallowedwithoutpermission.
Recommended publications
  • De Novo MEIS2 Mutation Causes Syndromic Developmental Delay with Persistent Gastro-Esophageal Reflux
    Journal of Human Genetics (2016) 61, 835–838 & 2016 The Japan Society of Human Genetics All rights reserved 1434-5161/16 www.nature.com/jhg SHORT COMMUNICATION De novo MEIS2 mutation causes syndromic developmental delay with persistent gastro-esophageal reflux Atsushi Fujita1, Bertrand Isidor2,3, Hugues Piloquet4, Pierre Corre5, Nobuhiko Okamoto6, Mitsuko Nakashima1, Yoshinori Tsurusaki1, Hirotomo Saitsu1, Noriko Miyake1 and Naomichi Matsumoto1 MEIS2 aberrations are considered to be the cause of intellectual disability, cleft palate and cardiac septal defect, as MEIS2 copy number variation is often observed with these phenotypes. To our knowledge, only one nucleotide-level change— specifically, an in-frame MEIS2 deletion—has so far been reported. Here, we report a female patient with a de novo nonsense mutation (c.611C4G, p.Ser204*) in MEIS2. She showed severe intellectual disability, moderate motor/verbal developmental delay, cleft palate, cardiac septal defect, hypermetropia, severe feeding difficulties with gastro-esophageal reflux and constipation. By reviewing this patient and previous patients with MEIS2 point mutations, we found that feeding difficulty with gastro-esophageal reflux appears to be one of the core clinical features of MEIS2 haploinsufficiency, in addition to intellectual disability, cleft palate and cardiac septal defect. Journal of Human Genetics (2016) 61, 835–838; doi:10.1038/jhg.2016.54; published online 26 May 2016 INTRODUCTION at the homeodomain may interfere with DNA binding. Moreover, Meis homeobox 2 (MEIS2;alsoknownasMRG1, NM_170677.4) this female patient also presented with various anomalous features encodes a homeobox (HOX) protein belonging to the three amino and developmental abnormalities. Here, we report on another acid loop extension (TALE) superfamily.
    [Show full text]
  • Detailed Review Paper on Retinoid Pathway Signalling
    1 1 Detailed Review Paper on Retinoid Pathway Signalling 2 December 2020 3 2 4 Foreword 5 1. Project 4.97 to develop a Detailed Review Paper (DRP) on the Retinoid System 6 was added to the Test Guidelines Programme work plan in 2015. The project was 7 originally proposed by Sweden and the European Commission later joined the project as 8 a co-lead. In 2019, the OECD Secretariat was added to coordinate input from expert 9 consultants. The initial objectives of the project were to: 10 draft a review of the biology of retinoid signalling pathway, 11 describe retinoid-mediated effects on various organ systems, 12 identify relevant retinoid in vitro and ex vivo assays that measure mechanistic 13 effects of chemicals for development, and 14 Identify in vivo endpoints that could be added to existing test guidelines to 15 identify chemical effects on retinoid pathway signalling. 16 2. This DRP is intended to expand the recommendations for the retinoid pathway 17 included in the OECD Detailed Review Paper on the State of the Science on Novel In 18 vitro and In vivo Screening and Testing Methods and Endpoints for Evaluating 19 Endocrine Disruptors (DRP No 178). The retinoid signalling pathway was one of seven 20 endocrine pathways considered to be susceptible to environmental endocrine disruption 21 and for which relevant endpoints could be measured in new or existing OECD Test 22 Guidelines for evaluating endocrine disruption. Due to the complexity of retinoid 23 signalling across multiple organ systems, this effort was foreseen as a multi-step process.
    [Show full text]
  • Prox1regulates the Subtype-Specific Development of Caudal Ganglionic
    The Journal of Neuroscience, September 16, 2015 • 35(37):12869–12889 • 12869 Development/Plasticity/Repair Prox1 Regulates the Subtype-Specific Development of Caudal Ganglionic Eminence-Derived GABAergic Cortical Interneurons X Goichi Miyoshi,1 Allison Young,1 Timothy Petros,1 Theofanis Karayannis,1 Melissa McKenzie Chang,1 Alfonso Lavado,2 Tomohiko Iwano,3 Miho Nakajima,4 Hiroki Taniguchi,5 Z. Josh Huang,5 XNathaniel Heintz,4 Guillermo Oliver,2 Fumio Matsuzaki,3 Robert P. Machold,1 and Gord Fishell1 1Department of Neuroscience and Physiology, NYU Neuroscience Institute, Smilow Research Center, New York University School of Medicine, New York, New York 10016, 2Department of Genetics & Tumor Cell Biology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, 3Laboratory for Cell Asymmetry, RIKEN Center for Developmental Biology, Kobe 650-0047, Japan, 4Laboratory of Molecular Biology, Howard Hughes Medical Institute, GENSAT Project, The Rockefeller University, New York, New York 10065, and 5Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 Neurogliaform (RELNϩ) and bipolar (VIPϩ) GABAergic interneurons of the mammalian cerebral cortex provide critical inhibition locally within the superficial layers. While these subtypes are known to originate from the embryonic caudal ganglionic eminence (CGE), the specific genetic programs that direct their positioning, maturation, and integration into the cortical network have not been eluci- dated. Here, we report that in mice expression of the transcription factor Prox1 is selectively maintained in postmitotic CGE-derived cortical interneuron precursors and that loss of Prox1 impairs the integration of these cells into superficial layers. Moreover, Prox1 differentially regulates the postnatal maturation of each specific subtype originating from the CGE (RELN, Calb2/VIP, and VIP).
    [Show full text]
  • A Conserved Tissue-Specific Homeodomain-Less Isoform of MEIS1 Is Downregulated in Colorectal Cancer
    Thomas Jefferson University Jefferson Digital Commons Department of Microbiology and Immunology Faculty Papers Department of Microbiology and Immunology 8-17-2011 A conserved tissue-specific homeodomain-less isoform of MEIS1 is downregulated in colorectal cancer. Richard C Crist Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia Jacquelyn J Roth Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia Scott A Waldman Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia Arthur M Buchberg Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia Follow this and additional works at: https://jdc.jefferson.edu/mifp Part of the Gastroenterology Commons, Medical Genetics Commons, Medical Microbiology Commons, Oncology Commons, and the Pathology Commons Let us know how access to this document benefits ouy Recommended Citation Crist, Richard C; Roth, Jacquelyn J; Waldman, Scott A; and Buchberg, Arthur M, "A conserved tissue-specific homeodomain-less isoform of MEIS1 is downregulated in colorectal cancer." (2011). Department of Microbiology and Immunology Faculty Papers. Paper 25. https://jdc.jefferson.edu/mifp/25 This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in Department of Microbiology and Immunology Faculty Papers by an authorized administrator of the Jefferson Digital Commons.
    [Show full text]
  • The Role of Meis1 in Hematopoietic Development Mi Cai Washington University in St
    Washington University in St. Louis Washington University Open Scholarship All Theses and Dissertations (ETDs) 8-31-2012 The Role of Meis1 in Hematopoietic Development Mi Cai Washington University in St. Louis Follow this and additional works at: https://openscholarship.wustl.edu/etd Recommended Citation Cai, Mi, "The Role of Meis1 in Hematopoietic Development" (2012). All Theses and Dissertations (ETDs). 944. https://openscholarship.wustl.edu/etd/944 This Dissertation is brought to you for free and open access by Washington University Open Scholarship. It has been accepted for inclusion in All Theses and Dissertations (ETDs) by an authorized administrator of Washington University Open Scholarship. For more information, please contact [email protected]. WASHINGTON UNIVERSITY IN ST. LOUIS Division of Biology and Biomedical Sciences Molecular Cell Biology Dissertation Examination Committee: Kenneth M. Murphy, Chair David C. Beebe Deepta Bhattacharya Raphael Kopan Kristen Kroll David M. Ornitz The Role of Meis1 in Hematopoietic Development By Mi Cai A dissertation presented to the Graduate School of Arts and Sciences of Washington University in partial fulfillment of the requirements for the degree of Doctor of Philosophy August 2012 Saint Louis, Missouri ABSTRACT OF THE DISSERTATION The Role of Meis1 in Hematopoietic Development By Mi Cai Doctor of Philosophy in Biology and Biomedical Sciences Molecular Cell Biology Washington University in St. Louis, 2012 Professor Kenneth M. Murphy, Chair Previous work has identified Mesp1 as an important regulator of the epithelial- mesenchymal transition (EMT) and of cardiovascular cell fate in differentiating embryonic stem cells (ESCs). To understand the molecular mechanisms underlying the actions of Mesp1, we sought to identify transcription targets of Mesp1.
    [Show full text]
  • A Single-Cell Transcriptome Atlas of the Mouse Glomerulus
    RAPID COMMUNICATION www.jasn.org A Single-Cell Transcriptome Atlas of the Mouse Glomerulus Nikos Karaiskos,1 Mahdieh Rahmatollahi,2 Anastasiya Boltengagen,1 Haiyue Liu,1 Martin Hoehne ,2 Markus Rinschen,2,3 Bernhard Schermer,2,4,5 Thomas Benzing,2,4,5 Nikolaus Rajewsky,1 Christine Kocks ,1 Martin Kann,2 and Roman-Ulrich Müller 2,4,5 Due to the number of contributing authors, the affiliations are listed at the end of this article. ABSTRACT Background Three different cell types constitute the glomerular filter: mesangial depending on cell location relative to the cells, endothelial cells, and podocytes. However, to what extent cellular heteroge- glomerular vascular pole.3 Because BP ad- neity exists within healthy glomerular cell populations remains unknown. aptation and mechanoadaptation of glo- merular cells are key determinants of kidney Methods We used nanodroplet-based highly parallel transcriptional profiling to function and dysregulated in kidney disease, characterize the cellular content of purified wild-type mouse glomeruli. we tested whether glomerular cell type sub- Results Unsupervised clustering of nearly 13,000 single-cell transcriptomes identi- sets can be identified by single-cell RNA fied the three known glomerular cell types. We provide a comprehensive online sequencing in wild-type glomeruli. This atlas of gene expression in glomerular cells that can be queried and visualized using technique allows for high-throughput tran- an interactive and freely available database. Novel marker genes for all glomerular scriptome profiling of individual cells and is cell types were identified and supported by immunohistochemistry images particularly suitable for identifying novel obtained from the Human Protein Atlas.
    [Show full text]
  • Full-Text.Pdf
    Systematic Evaluation of Genes and Genetic Variants Associated with Type 1 Diabetes Susceptibility This information is current as Ramesh Ram, Munish Mehta, Quang T. Nguyen, Irma of September 23, 2021. Larma, Bernhard O. Boehm, Flemming Pociot, Patrick Concannon and Grant Morahan J Immunol 2016; 196:3043-3053; Prepublished online 24 February 2016; doi: 10.4049/jimmunol.1502056 Downloaded from http://www.jimmunol.org/content/196/7/3043 Supplementary http://www.jimmunol.org/content/suppl/2016/02/19/jimmunol.150205 Material 6.DCSupplemental http://www.jimmunol.org/ References This article cites 44 articles, 5 of which you can access for free at: http://www.jimmunol.org/content/196/7/3043.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 23, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Systematic Evaluation of Genes and Genetic Variants Associated with Type 1 Diabetes Susceptibility Ramesh Ram,*,† Munish Mehta,*,† Quang T.
    [Show full text]
  • Mammalian PRC1 Complexes: Compositional Complexity and Diverse Molecular Mechanisms
    International Journal of Molecular Sciences Review Mammalian PRC1 Complexes: Compositional Complexity and Diverse Molecular Mechanisms Zhuangzhuang Geng 1 and Zhonghua Gao 1,2,3,* 1 Departments of Biochemistry and Molecular Biology, Penn State College of Medicine, Hershey, PA 17033, USA; [email protected] 2 Penn State Hershey Cancer Institute, Hershey, PA 17033, USA 3 The Stem Cell and Regenerative Biology Program, Penn State College of Medicine, Hershey, PA 17033, USA * Correspondence: [email protected] Received: 6 October 2020; Accepted: 5 November 2020; Published: 14 November 2020 Abstract: Polycomb group (PcG) proteins function as vital epigenetic regulators in various biological processes, including pluripotency, development, and carcinogenesis. PcG proteins form multicomponent complexes, and two major types of protein complexes have been identified in mammals to date, Polycomb Repressive Complexes 1 and 2 (PRC1 and PRC2). The PRC1 complexes are composed in a hierarchical manner in which the catalytic core, RING1A/B, exclusively interacts with one of six Polycomb group RING finger (PCGF) proteins. This association with specific PCGF proteins allows for PRC1 to be subdivided into six distinct groups, each with their own unique modes of action arising from the distinct set of associated proteins. Historically, PRC1 was considered to be a transcription repressor that deposited monoubiquitylation of histone H2A at lysine 119 (H2AK119ub1) and compacted local chromatin. More recently, there is increasing evidence that demonstrates the transcription activation role of PRC1. Moreover, studies on the higher-order chromatin structure have revealed a new function for PRC1 in mediating long-range interactions. This provides a different perspective regarding both the transcription activation and repression characteristics of PRC1.
    [Show full text]
  • BMC Biology Biomed Central
    BMC Biology BioMed Central Research article Open Access Classification and nomenclature of all human homeobox genes PeterWHHolland*†1, H Anne F Booth†1 and Elspeth A Bruford2 Address: 1Department of Zoology, University of Oxford, South Parks Road, Oxford, OX1 3PS, UK and 2HUGO Gene Nomenclature Committee, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK Email: Peter WH Holland* - [email protected]; H Anne F Booth - [email protected]; Elspeth A Bruford - [email protected] * Corresponding author †Equal contributors Published: 26 October 2007 Received: 30 March 2007 Accepted: 26 October 2007 BMC Biology 2007, 5:47 doi:10.1186/1741-7007-5-47 This article is available from: http://www.biomedcentral.com/1741-7007/5/47 © 2007 Holland et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: The homeobox genes are a large and diverse group of genes, many of which play important roles in the embryonic development of animals. Increasingly, homeobox genes are being compared between genomes in an attempt to understand the evolution of animal development. Despite their importance, the full diversity of human homeobox genes has not previously been described. Results: We have identified all homeobox genes and pseudogenes in the euchromatic regions of the human genome, finding many unannotated, incorrectly annotated, unnamed, misnamed or misclassified genes and pseudogenes.
    [Show full text]
  • A Grainyhead-Like 2/Ovo-Like 2 Pathway Regulates Renal Epithelial Barrier Function and Lumen Expansion
    BASIC RESEARCH www.jasn.org A Grainyhead-Like 2/Ovo-Like 2 Pathway Regulates Renal Epithelial Barrier Function and Lumen Expansion † ‡ | Annekatrin Aue,* Christian Hinze,* Katharina Walentin,* Janett Ruffert,* Yesim Yurtdas,*§ | Max Werth,* Wei Chen,* Anja Rabien,§ Ergin Kilic,¶ Jörg-Dieter Schulzke,** †‡ Michael Schumann,** and Kai M. Schmidt-Ott* *Max Delbrueck Center for Molecular Medicine, Berlin, Germany; †Experimental and Clinical Research Center, and Departments of ‡Nephrology, §Urology, ¶Pathology, and **Gastroenterology, Charité Medical University, Berlin, Germany; and |Berlin Institute of Urologic Research, Berlin, Germany ABSTRACT Grainyhead transcription factors control epithelial barriers, tissue morphogenesis, and differentiation, but their role in the kidney is poorly understood. Here, we report that nephric duct, ureteric bud, and collecting duct epithelia express high levels of grainyhead-like homolog 2 (Grhl2) and that nephric duct lumen expansion is defective in Grhl2-deficient mice. In collecting duct epithelial cells, Grhl2 inactivation impaired epithelial barrier formation and inhibited lumen expansion. Molecular analyses showed that GRHL2 acts as a transcrip- tional activator and strongly associates with histone H3 lysine 4 trimethylation. Integrating genome-wide GRHL2 binding as well as H3 lysine 4 trimethylation chromatin immunoprecipitation sequencing and gene expression data allowed us to derive a high-confidence GRHL2 target set. GRHL2 transactivated a group of genes including Ovol2, encoding the ovo-like 2 zinc finger transcription factor, as well as E-cadherin, claudin 4 (Cldn4), and the small GTPase Rab25. Ovol2 induction alone was sufficient to bypass the requirement of Grhl2 for E-cadherin, Cldn4,andRab25 expression. Re-expression of either Ovol2 or a combination of Cldn4 and Rab25 was sufficient to rescue lumen expansion and barrier formation in Grhl2-deficient collecting duct cells.
    [Show full text]
  • The BAF45D Protein Is Preferentially Expressed in Adult Neurogenic Zones and in Neurons and May Be Required for Retinoid Acid Induced PAX6 Expression
    ORIGINAL RESEARCH published: 06 November 2017 doi: 10.3389/fnana.2017.00094 The BAF45D Protein Is Preferentially Expressed in Adult Neurogenic Zones and in Neurons and May Be Required for Retinoid Acid Induced PAX6 Expression Chao Liu 1, 2, 3*†, Ruyu Sun 1, 2, 3†, Jian Huang 4†, Dijuan Zhang 1, 2, 3, Dake Huang 1, Weiqin Qi 1, Shenghua Wang 1, 2, 3, Fenfen Xie 1, 2, 3, Yuxian Shen 1 and Cailiang Shen 4* 1 School of Basic Medical Sciences, Anhui Medical University, Hefei, China, 2 Department of Histology and Embryology, Anhui Medical University, Hefei, China, 3 Institute of Stem Cell and Tissue Engineering, Anhui Medical University, Hefei, China, 4 Department of Spine Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China Adult neurogenesis is important for the development of regenerative therapies for human diseases of the central nervous system (CNS) through the recruitment of adult neural stem cells (NSCs). NSCs are characterized by the capacity to generate neurons, Edited by: Daniel A. Peterson, astrocytes, and oligodendrocytes. To identify key factors involved in manipulating the Rosalind Franklin University of adult NSC neurogenic fate thus has crucial implications for the clinical application. Here, Medicine and Science, United States we report that BAF45D is expressed in the subgranular zone (SGZ) of the dentate gyrus, Reviewed by: Richard S. Nowakowski, the subventricular zone (SVZ) of the lateral ventricle, and the central canal (CC) of the Florida State University College of adult spinal cord. Coexpression of BAF45D with glial fibrillary acidic protein (GFAP), a Medicine, United States radial glial like cell marker protein, was identified in the SGZ, the SVZ and the adult spinal Tobias David Merson, Australian Regenerative Medicine cord CC.
    [Show full text]
  • Stage-Dependent Differential Gene Expression Profiles of Cranial
    bioRxiv preprint doi: https://doi.org/10.1101/432302; this version posted October 1, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 2 3 4 Stage-Dependent Differential Gene Expression Profiles of Cranial 5 Neural Crest Cells Derived from Mouse Induced Pluripotent Stem 6 Cells 7 8 9 Ayano Odashima1¶, Shoko Onodera2, Akiko Saito2, Takashi Nakamura2, Yuuki Ogihara3, 10 Tatsuya Ichinohe3, Toshifumi Azuma1,2* 11 12 13 1 Department of Oral Health Science Center, Tokyo Dental College, Tokyo, Japan 14 15 2 Department of Biochemistry, Tokyo Dental College, Tokyo, Japan 16 17 3 Department of Dental Anesthesiology, Tokyo Dental College, Tokyo, Japan 18 19 ¶These authors contributed equally to this work. 20 *Corresponding author 21 E-mail [email protected] 22 1 bioRxiv preprint doi: https://doi.org/10.1101/432302; this version posted October 1, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 23 Abstract 24 Cranial neural crest cells (cNCCs) comprise a multipotent population of cells that migrate into 25 the pharyngeal arches of the vertebrate embryo and differentiate into a broad range of derivatives 26 of the craniofacial organs. Consequently, migrating cNCCs are considered as one of the most 27 attractive candidate sources of cells for regenerative medicine.
    [Show full text]